Tracking fetal development through molecular analysis of maternal biofluids

Area of Science:

• Reproductive Medicine
• Genetics
• Molecular Biology

Background:

• Current fetal development monitoring relies on invasive procedures like amniocentesis and ultrasonography.
• Noninvasive prenatal diagnosis (NIPD) has advanced significantly using cell-free fetal (cff) nucleic acids in maternal plasma.
• These nucleic acids, primarily from the placenta, enable detection of fetal sex, RhD genotype, and aneuploidy.

Purpose of the Study:

• To comprehensively review the molecular analysis of cell-free fetal nucleic acids in maternal biofluids.
• To elucidate mechanisms of fetal development, physiology, and pathology through cff nucleic acid analysis.
• To highlight the potential of cff nucleic acids in amniotic fluid for real-time fetal information.

Main Methods:

• Review of current literature on noninvasive prenatal diagnosis.
• Analysis of cell-free fetal nucleic acids in maternal plasma and amniotic fluid.
• Focus on molecular techniques for genetic and biochemical analysis.

Main Results:

• NIPD via maternal plasma cff nucleic acids is established for fetal sex, RhD, and aneuploidy.
• Cff nucleic acids in amniotic fluid originate directly from the fetus, offering higher concentrations and real-time data.
• Molecular analysis of cff nucleic acids aids in understanding fetal development and disease.

Conclusions:

• Cell-free fetal nucleic acids in maternal biofluids are crucial for advancing prenatal diagnosis and fetal health monitoring.
• Amniotic fluid cff nucleic acids offer unique advantages for real-time fetal gene expression and developmental insights.
• This review underscores the potential of cff nucleic acid analysis in reproductive failure research.